about
Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cellsTrial WatchOn evolutionary origin of cancerRevisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapyEffector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseRANK-RANKL signalling in cancerTargeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)Immunological interactions in radiotherapy-opening a new window of opportunityDiagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal CancerSquamous cell carcinoma and dental implants: A systematic review of case reportsThe relationship between COPD and lung cancerThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyThe complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activityCombining radiation and immunotherapy: a new systemic therapy for solid tumors?Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccinesSpecific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasisSystematic review of CYFRA 21-1 as a prognostic indicator and its predictive correlation with clinicopathological features in Non-small Cell Lung Cancer: A meta-analysisAn overview on the role of dietary phenolics for the treatment of cancersTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsTrial Watch-Immunostimulation with cytokines in cancer therapyMolecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistanceRegulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyImportance of metabolic rate to the relationship between the number of genes in a functional category and body size in Peto's paradox for cancerCancer: evolutionary, genetic and epigenetic aspectsCXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.Inflammation and the two-hit hypothesis of schizophrenia.Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men.Nitric oxide is a key component in inflammation-accelerated tumorigenesis.A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.Pathway-based classification of cancer subtypes.Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response.Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Cytokine plasma levels: reliable predictors for radiation pneumonitis?Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.Differences in the tumor microenvironment between African-American and European-American breast cancer patientsPhase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinomaNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy.
P2860
Q24299700-104F225A-DA3B-4C0F-8BE4-72C3F68558CBQ24618653-41B1353A-FBBD-4557-8B87-F6F7DD36FF88Q24803579-B8760BC0-96A7-4548-A273-BF8872BE83F4Q24805285-B84F3EE7-35D2-4C64-970F-2817424BDEA8Q26744527-5720503B-A857-4AA0-BDF0-E11A6CE45495Q26747442-0ACA1BC3-A2AD-4E59-8259-23071DC4A016Q26765429-E55C42FE-2A40-4F6B-9D21-620AFED61400Q26767178-36784624-C7A6-42D0-A5F5-930FA389DC0CQ26772049-C15DD88B-254B-4960-BD77-776F96F02852Q26779817-93535510-574E-4B7B-B4B3-106C58E7BD34Q26781337-DC014C08-90F7-4EF3-B8B2-13A6CD6A3B7FQ26783291-17900316-95BD-4784-85C9-06273C3EA597Q26851545-03719FBB-B24C-41DE-BE25-3C3C98A3E66CQ26991721-8C0A3B61-74B4-4349-8B02-E1DC74D79D0BQ27030560-DA4A50A6-330F-44D1-847D-149F49DD3DB4Q27310303-6CC89BAC-6869-4300-A4BB-14A8D8DC4BABQ28066963-E8398C40-7094-4BA6-8DBF-0793B6C5E982Q28071894-D4737B67-6C4C-458B-9650-B27949FC0FE4Q28078154-E02DFFB3-C604-4618-B39C-DA999FD87C90Q28078725-1F72454B-791B-44D6-8C22-FE5642D0837CQ28307294-5BABCC9B-B462-41C2-934E-904C771FB5EFQ28386983-C4EC5239-95C7-4116-804B-33D1398D53EAQ28598169-8576FAF9-3D09-485E-86FA-6F6203C77CFCQ28728960-04D6E24F-83EF-4F98-8CCD-B7B0DBBA4820Q30358993-8A696D71-B5E9-43A3-890F-B80D864596FEQ30422062-3C7F1022-1388-4B08-92F9-F073829CD1B9Q30431623-0D9464D0-4B2F-45B6-B7A9-81A2B1CDF1C9Q30438755-EEDA3605-0269-44C0-A18C-556FB4E6E7DCQ30490198-FA1AD532-DB81-46F4-9150-812B864AF01BQ30527843-8F7BCB6D-44E2-4CFA-AB2B-D83E15FFA156Q33221445-83BD34FB-FB07-42B7-AF2A-E9F3171FFD9BQ33224181-6FA64561-8BF2-45B1-A7F3-9DAA6E6B2EDDQ33358117-96170C84-28B2-4E17-8C9F-6E0BDE781164Q33384384-F69BCB6F-1731-4610-AFEA-BFFFEDC2A598Q33410258-C7F57846-91B6-4CB3-895A-87CDC1E75013Q33413155-B26F7298-424F-45D8-99DC-FC1562E69E17Q33621881-F70DA423-6B1F-44AA-8B05-BABCB7D6D052Q33641747-97BB242B-D85F-40C6-AF7E-70358F0DAA48Q33664095-8F019097-F88F-4547-9113-A9499D772F9FQ33664499-728D27B7-6252-4555-A951-CE786ABE475F
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cytokines in cancer pathogenesis and cancer therapy.
@ast
Cytokines in cancer pathogenesis and cancer therapy.
@en
Cytokines in cancer pathogenesis and cancer therapy.
@nl
type
label
Cytokines in cancer pathogenesis and cancer therapy.
@ast
Cytokines in cancer pathogenesis and cancer therapy.
@en
Cytokines in cancer pathogenesis and cancer therapy.
@nl
prefLabel
Cytokines in cancer pathogenesis and cancer therapy.
@ast
Cytokines in cancer pathogenesis and cancer therapy.
@en
Cytokines in cancer pathogenesis and cancer therapy.
@nl
P356
P1476
Cytokines in cancer pathogenesis and cancer therapy.
@en
P2093
Glenn Dranoff
P2888
P356
10.1038/NRC1252
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1037065448